SF3B1 and myelodysplastic syndrome: We observed a striking influence of additional mutations on patients with STAT5B N642H that mirrors established associations in related myeloid disorders, particularly the relatively good prognostic influence of SF3B1 mutations and the adverse influence of multiple mutations, both of which have been described in MDS [36, 37].